In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia

被引:192
作者
Wiemels, JL
Xiao, ZJ
Buffler, PA
Maia, AT
Ma, XM
Dicks, BM
Smith, MT
Zhang, LP
Feusner, J
Wiencke, J
Pritchard-Jones, K
Kempski, H
Greaves, M
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, Lab Mol Epidemiol, San Francisco, CA 94143 USA
[2] Inst Canc Res, Leukaemia Res Fund Ctr, London SW3 6JB, England
[3] Inst Child Hlth, Leukaemia Res Fund Ctr, Mol Haematol & Canc Biol Unit, London, England
[4] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA
[5] Childrens Hosp, Dept Hematol Oncol, Oakland, CA 94609 USA
[6] Royal Marsden Hosp, Childrens Canc Unit, Surrey, England
关键词
D O I
10.1182/blood.V99.10.3801
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent reports have established the prenatal origin of leukemia translocations and resultant fusion genes in some patients, including MLL-AF4 translocations in infants and TEL-AML1 translocations in children. We now report evidence for the prenatal origin of a translocation in childhood acute myeloid leukemia (AML). The t(8;21) AML1-ETO translocations were sequenced at the genomic level in 10 diagnostic leukemia samples from children with available neonatal Guthrie blood spots. Clonotypic genomic AML1-ETO sequences were detected in the Guthrie spots for 5 individuals, providing unambiguous evidence of prenatal origin in these cases. Two of these patients were older than 10 years of age at diagnosis, indicative of a protracted postnatal latency. Three of the patients were assessed for the persistence of genomic fusion sequences in complete clinical remission samples and were found to be positive. These data indicate that t(8;21) in childhood AML can arise in utero, possibly as an initiating event in childhood AML, and may establish a long-lived or stable parental clone that requires additional secondary genetic alterations to cause leukemia. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3801 / 3805
页数:5
相关论文
共 34 条
[11]   THE T(8-14) CHROMOSOMAL TRANSLOCATION OCCURRING IN B-CELL MALIGNANCIES RESULTS FROM MISTAKES IN V-D-J JOINING [J].
HALUSKA, FG ;
FINVER, S ;
TSUJIMOTO, Y ;
CROCE, CM .
NATURE, 1986, 324 (6093) :158-161
[12]  
Higuchi M, 2000, BLOOD, V96, p222A
[13]   Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients [J].
Krauter, J ;
Wattjes, MP ;
Nagel, S ;
Heidenreich, O ;
Krug, U ;
Kafert, S ;
Bunjes, D ;
Bergmann, L ;
Ganser, A ;
Heil, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (01) :80-85
[14]  
KUSEC R, 1994, LEUKEMIA, V8, P735
[15]   Molecular tracking of leukemogenesis in a triplet pregnancy [J].
Maia, AT ;
Ford, AM ;
Jalali, GR ;
Harrison, CJ ;
Taylor, GM ;
Eden, OB ;
Greaves, MF .
BLOOD, 2001, 98 (02) :478-482
[16]   AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation [J].
Miyamoto, T ;
Weissman, IL ;
Akashi, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7521-7526
[17]   Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia [J].
Miyamoto, T ;
Nagafuji, K ;
Akashi, K ;
Harada, M ;
Kyo, T ;
Akashi, T ;
Takenaka, K ;
Mizuno, S ;
Gondo, H ;
Okamura, T ;
Dohy, H ;
Niho, Y .
BLOOD, 1996, 87 (11) :4789-4796
[18]   Karyotype and age in acute myeloid leukemia. Are they linked? [J].
Moorman, AV ;
Roman, E ;
Willett, EV ;
Dovey, GJ ;
Cartwright, RA ;
Morgan, GJ .
CANCER GENETICS AND CYTOGENETICS, 2001, 126 (02) :155-161
[19]  
NUCIFORA G, 1993, BLOOD, V82, P712
[20]   Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): the DNA damage-repair model of translocation [J].
Reichel, M ;
Gillert, E ;
Nilson, I ;
Siegler, G ;
Greil, J ;
Fey, GH ;
Marschalek, R .
ONCOGENE, 1998, 17 (23) :3035-3044